China CAS:223673-61-8 Manufacturer

CPhI is the undisputed leader in the pharmaceutical industry. CPhI China offers a key access point to the second largest pharma market in the world. The exhibition features over 3,000 companies and incorporates various API showcases like bioLIVE, iCSE, NEX and FDF, creating a comprehensive platform that connects the entire pharmaceutical industry chain in the Asian-Pacific region.

The API -- cyproterone acetate, successfully passed the EU-GMP audit in April 2024.

CPHI China will be staged at Shanghai New International Expo Center on June 24-26, 2025 together with ICSE & PMEC China,our booth number is W1G20(b).

CPHI Frankfurt 2025 will be held at Messe Frankfurt from October 28 to 30, our booth number is 12.1C3.

I've spent over twenty years working with companies like yours, and if there's one question I hear more than any other, it's this one. Selecting the right intermediates can feel like a high-stakes puzzle, where one wrong piece can impact your entire production line. It’s a decision that goes beyond mere cost; it's about partnership, reliability, and the integrity of your final product. In my journey, I've seen how a strategic partnership with a focused manufacturer like Humanwell Pharmaceutical can transform this challenging task from a source of anxiety into a competitive advantage. Let's break down the critical parameters you need to consider.

Finasteride is one of the most widely researched and prescribed medications for treating male pattern hair loss and benign prostatic hyperplasia (BPH). By targeting the hormonal pathways responsible for hair follicle miniaturization and prostate enlargement, Finasteride has become a cornerstone pharmaceutical ingredient in dermatology and urology. This in-depth guide explores how Finasteride works, its benefits, dosage, safety profile, side effects, comparisons with alternatives, and why global pharmaceutical manufacturers such as Humanwell play a crucial role in its production and supply.